Correlation of endogenous hormonal levels, fibroglandular tissue volume and percent density measured using 3D MRI during one menstrual cycle.
暂无分享,去创建一个
M. Su | C. McLaren | J. Chen | J. Chen | D. Yeh | W. P. Chen | S. Chan | W. Chen
[1] A. Jakobsen,et al. A randomized phase III trial on maintenance treatment with bevacizumab alone or in combination with erlotinib after chemotherapy and bevacizumab in metastatic colorectal cancer: the Nordic ACT Trial. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.
[2] S. Feig,et al. Menstrual cycle-related fluctuations in breast density measured by using three-dimensional MR imaging. , 2011, Radiology.
[3] Bernard Rosner,et al. Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. , 2011, Journal of the National Cancer Institute.
[4] Hein Putter,et al. Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial , 2011, The Lancet.
[5] O. Nalcioglu,et al. A new bias field correction method combining N3 and FCM for improved segmentation of breast density on MRI. , 2010, Medical physics.
[6] P. Lønning. The potency and clinical efficacy of aromatase inhibitors across the breast cancer continuum , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[7] Catherine Klifa,et al. Magnetic resonance imaging for secondary assessment of breast density in a high-risk cohort. , 2010, Magnetic resonance imaging.
[8] Scott Devine,et al. Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer , 2010, Breast Cancer Research and Treatment.
[9] A. Rademaker,et al. A prospective study of variability in mammographic density during the menstrual cycle , 2010, Breast Cancer Research and Treatment.
[10] Michael Khazen,et al. Assessing the usefulness of a novel MRI-based breast density estimation algorithm in a cohort of women at high genetic risk of breast cancer: the UK MARIBS study , 2009, Breast Cancer Research.
[11] V. McCormack,et al. Premenopausal mammographic density in relation to cyclic variations in endogenous sex hormone levels, prolactin, and insulin-like growth factors. , 2009, Cancer research.
[12] N. Boyd,et al. Differences in Measured Mammographic Density in the Menstrual Cycle , 2009, Cancer Epidemiology Biomarkers & Prevention.
[13] K. Newton,et al. Associations between endogenous sex hormone levels and mammographic and bone densities in premenopausal women , 2006, Cancer Causes & Control.
[14] Michael Khazen,et al. A Pilot Study of Compositional Analysis of the Breast and Estimation of Breast Mammographic Density Using Three-Dimensional T1-Weighted Magnetic Resonance Imaging , 2008, Cancer Epidemiology Biomarkers & Prevention.
[15] Sheila Prindiville,et al. Effect of Raloxifene on Mammographic Density and Breast Magnetic Resonance Imaging in Premenopausal Women at Increased Risk for Breast Cancer , 2008, Cancer Epidemiology Biomarkers & Prevention.
[16] Min-Ying Su,et al. Development of a quantitative method for analysis of breast density based on three-dimensional breast MRI. , 2008, Medical physics.
[17] T. Whelan,et al. The feasibility and responsiveness of the health utilities index in patients with early-stage breast cancer: A prospective longitudinal study , 2008, Quality of Life Research.
[18] K. Chao,et al. Standard and low-dose hormone therapy for postmenopausal women--focus on the breast. , 2007, Taiwanese journal of obstetrics & gynecology.
[19] S. Cummings,et al. Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model. , 2007, Endocrine-related cancer.
[20] N. Boyd,et al. Mammographic density and the risk and detection of breast cancer. , 2007, The New England journal of medicine.
[21] V. Shane Pankratz,et al. Mammographic Breast Density as a General Marker of Breast Cancer Risk , 2007, Cancer Epidemiology Biomarkers & Prevention.
[22] R. Chlebowski,et al. Adherence to Endocrine Therapy for Breast Cancer , 2007, Oncology.
[23] D. Miglioretti,et al. Mammographic Breast Density, Dense Area, and Breast Area Differences by Phase in the Menstrual Cycle , 2006, Cancer Epidemiology Biomarkers & Prevention.
[24] Anna Chiarelli,et al. Body Size, Mammographic Density, and Breast Cancer Risk , 2006, Cancer Epidemiology Biomarkers & Prevention.
[25] D. Spiegelman,et al. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. , 2006, Journal of the National Cancer Institute.
[26] J. Cline,et al. Effects of soy on the mammary glands of premenopausal female monkeys. , 2006, Fertility and sterility.
[27] G. Maskarinec,et al. Mammographic densities and circulating hormones: a cross-sectional study in premenopausal women. , 2006, Breast.
[28] M. Stockler,et al. Patients' preferences for adjuvant endocrine therapy in early breast cancer: what makes it worthwhile? , 2005, British Journal of Cancer.
[29] Daniel B Kopans,et al. Physiologic Changes in Breast Magnetic Resonance Imaging during the Menstrual Cycle: Perfusion Imaging, Signal Enhancement, and Influence of the T1 Relaxation Time of Breast Tissue , 2005, The breast journal.
[30] J. Stines,et al. The normal breast and its variations in mammography. , 2005, European journal of radiology.
[31] P. Muti. The role of endogenous hormones in the etiology and prevention of breast cancer: the epidemiological evidence. , 2005, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[32] Berkman Sahiner,et al. Correlation between mammographic density and volumetric fibroglandular tissue estimated on breast MR images. , 2004, Medical physics.
[33] Karla Kerlikowske,et al. Mammographic breast density and family history of breast cancer. , 2003, Journal of the National Cancer Institute.
[34] G. Adam,et al. MR-Mammographie bei 0,5 Tesla: Menstruationszyklusabhängigkeit der Kontrastmittelanreicherung unter hormoneller Kontrazeption? , 2003 .
[35] G. Adam,et al. [MR-imaging of the breast at 0.5 Tesla: menstrual-cycle dependency of parenchymal contrast enhancement in healthy volunteers with oral contraceptive use?]. , 2003, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.
[36] Seema A. Khan,et al. Morphological Changes in Breast Tissue with Menstrual Cycle , 2002, Modern Pathology.
[37] Celine M Vachon,et al. Case-control study of increased mammographic breast density response to hormone replacement therapy. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[38] N F Boyd,et al. The association of breast mitogens with mammographic densities , 2002, British Journal of Cancer.
[39] W. Rakowski,et al. Adjuvant tamoxifen prescription in women 65 years and older with primary breast cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] G C McKinnon,et al. Menstrual cycle variation of apparent diffusion coefficients measured in the normal breast using MRI , 2001, Journal of magnetic resonance imaging : JMRI.
[41] S. Jansen,et al. Stability of Patients’ Preferences for Chemotherapy , 2001, Medical decision making : an international journal of the Society for Medical Decision Making.
[42] M. Pike,et al. Mammographic density changes during the menstrual cycle. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[43] N Roberts,et al. Estimation of breast volume and its variation during the menstrual cycle using MRI and stereology. , 1999, The British journal of radiology.
[44] J. Weinman,et al. The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication , 1999 .
[45] E. Merkle,et al. MR mammography: influence of menstrual cycle on the dynamic contrast enhancement of fibrocystic disease , 1999, European Radiology.
[46] E White,et al. Variation in mammographic breast density by time in menstrual cycle among women aged 40-49 years. , 1998, Journal of the National Cancer Institute.
[47] P. Ravdin,et al. Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[48] C. Claussen,et al. Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. , 1997, Radiology.
[49] S. J. Graham,et al. Quantitative correlation of breast tissue parameters using magnetic resonance and X-ray mammography. , 1996, British Journal of Cancer.
[50] D B Plewes,et al. Changes in fibroglandular volume and water content of breast tissue during the menstrual cycle observed by MR imaging at 1.5 t , 1995, Journal of magnetic resonance imaging : JMRI.
[51] M. Pike,et al. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. , 1993, Epidemiologic reviews.
[52] L. Bernstein,et al. Endogenous hormones and breast cancer risk. , 1993, Epidemiologic reviews.
[53] Horton,et al. Annals of Oncology , 1991, Springer US.
[54] P A Fowler,et al. Cyclic changes in composition and volume of the breast during the menstrual cycle, measured by magnetic resonance imaging , 1990, British journal of obstetrics and gynaecology.
[55] M. Pike,et al. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. , 1988, European journal of cancer & clinical oncology.
[56] A. Morrison,et al. Endogenous sex hormones, prolactin, and mammographic features of breast tissue in premenopausal women. , 1986, Journal of the National Cancer Institute.
[57] T. Longacre,et al. A Correlative Morphologic Study of Human Breast and Endometrium in the Menstrual Cycle , 1986, The American journal of surgical pathology.
[58] D. G. Hoel,et al. ‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancer , 1983, Nature.
[59] F. Vogel,et al. The correlation of histologic changes in the human breast with the menstrual cycle. , 1981, The American journal of pathology.
[60] S. Holm. A Simple Sequentially Rejective Multiple Test Procedure , 1979 .